ProCE Banner Activity

Applying HER2 Testing Results to Treatment Decisions for Patients With Solid Tumors

Slideset

Download this slideset for expert perspectives and key data on HER2-targeted therapy for specific patients with advanced breast, gastroesophageal, colorectal, and lung cancers, as well as a discussion of emerging strategies for HER-altered solid tumors.

Released: March 25, 2024

Expiration: March 24, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Jazz Pharmaceuticals, and Seagen.

AstraZeneca

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals

Seagen